沙特阿拉伯药品质量使用 (QUM) 计划和策略的有效性:叙述性审查
Fahad Aldhafeeri1, Andrew Wilson1, Shaun Larkin1
1Leeder Centre for Health Policy, Economics and Data, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
Drug, healthcare and patient safety
|March 31, 2025
概括
沙特阿拉伯 沙特阿拉伯 沙特阿拉伯
科学领域:
- 医疗保健服务研究 医疗服务研究
- 制药科学 制药科学
- 公共卫生 公共卫生
背景情况:
- 在沙特阿拉伯,慢性疾病的高发病率,劳动力短缺和多药店挑战了药物的使用.
- 沙特卫生部 (MOH) 已经实施了药品质量使用 (QUM) 计划,包括药物安全倡议和技术采用.
- 现有的QUM策略旨在在复杂的医疗需求中改善患者的治疗结果.
研究的目的:
- 系统地审查和评估有关沙特阿拉伯药品质量使用 (QUM) 干预措施的文献.
- 评估沙特卫生保健系统中已公布的QUM方法的范围,质量和有效性.
- 识别差距和机会,以提高药物安全性和患者的结果.
主要方法:
- 在Scopus,Medline和PubMed进行了全面的文献搜索.
- 搜索的重点是评估药品质量使用 (QUM) 的研究,沙特阿拉伯实施的干预措施和计划.
- 包括有关这些QUM倡议成果和有效性的研究报告.
主要成果:
- 常见的QUM项目包括药物调和,药剂师干预,抗生素管理和健康信息技术.
- 评估表明,对健康结果,处方,慢性疾病管理和成本降低有显著的积极影响.
- 药物调和减少了高达20%的差异,药剂师的干预改善了安全性,管理计划减少了抗菌素的使用和成本.
结论:
- 沙特阿拉伯已经制定了国家QUM政策和计划,证明了积极的影响.
- 需要进一步的大规模,多中心的研究,以全面了解QUM实践.
- 建议严格评估和扩展QUM计划,以进一步提高药物安全性和患者的治疗结果.
相关概念视频
01:26Methods Of Healthcare Delivery System
3.9K
At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
3.9K
01:25Drug Regulation
3.0K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.0K
01:19Pharmacovigilance
2.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K
01:28Structure-Activity Relationships and Drug Design
1.9K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.9K
01:03Drug Control Governance: Regulatory Bodies and Their Impact
710
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
710
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
366
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
366